Itraconazole in Combination With Ablation for the Prevention of Esophageal Cancer in Patients With High-risk Barrett's Esophagus
Conditions
Barrett Esophagus · Clinical Stage I Esophageal Adenocarcinoma AJCC v8 · Clinical Stage IIA Esophageal Adenocarcinoma AJCC v8 · Esophageal Adenocarcinoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
University of Kansas Cancer Center, Kansas City, Kansas, United States
Contact: Principal Investigator (Ajay Bansal)University of Michigan Rogel Cancer Center, Ann Arbor, Michigan, United States
Contact: Principal Investigator (David Wang)Washington University School of Medicine, St Louis, Missouri, United States
Contact: Principal Investigator (Paul E. Wise)UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States
Contact: Principal Investigator (Nicholas J. Shaheen)Case Western Reserve University, Cleveland, Ohio, United States
Contact: Principal Investigator (Amitabh Chak)Baylor University Medical Center, Dallas, Texas, United States
Contact: Principal Investigator (Vani Konda)
Study leads
Ajay Bansal, MD
Principal Investigator
University of Kansas Medical Center